MedWatch

Innovation Fund Denmark will direct investments towards "transforming" trend in the pharmaceutical industry

A new, three year investment strategy by Innovation Fund Denmark will support a new trend on more personalized medicine in the health sector and the pharmaceutical industry.

A fundamental change is underway in the health sector as in the future patients will be offered medical treatment based on the individual's biological criteria to a greater extent than previously, rather than a standardized treatment plan.

The treatment strategy - known as personalized or precision medicine - already has the Danish Government and the health sector's attention, and now Innovation Fund Denmark is ready with a three year strategy on investments in projects that will create progress in the development of more targeted treatments.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Patienter må vente længere på ny medicin

Siden Medicinrådet blev etableret i 2017, er patienternes ventetid på ny medicin blevet tre gange længere, konkluderer en analyse fra Lif, der vil have Medicinrådet til at droppe unødvendige vurderingsmetoder. Medicinrådet arbejder på at nedbringe sagsbehandlingstiderne.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier